Future technologies are in need of solid-state materials showing the desired chemical and physical properties, and designing such materials requires a proper understanding of their electronic structures. In this context, recent research on chalcogenides, which were classified as ‘incipient metals’ and included phase-change data storage materials as well as thermoelectrics, revealed a remarkable electronic behavior and possible state (dubbed ‘metavalency’) proposed for the frontier between entire electron localization and delocalization. Because the members of the family of the polar intermetallics vary widely in their properties as well as electronic structures, one may wonder if the aforementioned electronic characteristics are also achieved for certain polar intermetallics. To answer this question, we have employed quantum-chemical tools to examine the electronic structures of the rock salt-type YTe and SnTe belonging to the families of the polar intermetallics and incipient metals, respectively. To justify these classifications and argue as to why an application of the Zintl–Klemm concept (frequently employed to relate the structural features of tellurides to their electronic structures) could be misleading for YTe and SnTe, the electronic structures of YTe and SnTe were first compared to that of the rock salt-type SrTe. In addition, we carried out a Gedankenexperiment by subsequently modifying the chemical composition from YTe to SnTe, and, by doing so, we shed new light on the interdependence between chemical bonding and materials properties. Gradual changes in the former do not necessarily translate into the latter which may undergo discontinuous modifications.Future technologies are in need of solid-state materials showing the desired chemical and physical properties, and designing such materials requires a proper understanding of their electronic structures.相似文献
Vitiligo is an autoimmune dermatologic disorder that causes chronic skin depigmentation, which affects an estimated 1% of the world's population. This disfiguring condition can have devastating psychological consequences on its sufferers. The field of psychodermatology examines psychiatric manifestations of dermatologic conditions. Although previous research in this area has been done on other skin disorders, no large‐scale review exists on the dermatologic‐psychiatric connection in vitiligo specifically. The current article will discuss the psychodermatology of vitiligo with an emphasis on depression, stress, and low self‐esteem. The social and cultural considerations will also be explored. Finally, the implications of these psychiatric manifestations on treatment will be discussed, with the goal of implementing early psychiatric intervention for those with vitiligo. 相似文献
Thalamic and corticocortical connections of the second somatic sensory area (SII) in the mouse cerebral cortex were investigated by means of the retrograde transport of horseradish peroxidase. Focal injections of the enzyme were made in physiologically determined locations within the parietal cortex. Results show that SII receives substantial inputs from topographically appropriate regions within the ipsilateral ventrobasal nucleus and from the ipsilateral posterior group. The limb representation, which was previously found to be responsive to auditory stimulation, received inputs also from the medial division of the medial geniculate body. The SII face representation, which is largely unresponsive to auditory stimuli, received little or no input from the medial geniculate body. SII injections yielded retrograde labeling in the topographically appropriate region in the first somatic sensory area (SI), and SI injections retrogradely labeled cells in SII in a pattern consistent with previous electrophysiological maps. Homotypical regions within SI and SII therefore appear to be reciprocally interconnected. SII also receives inputs from the ipsilateral motor cortex and from contralateral SI and SII. Finally, injections into the SI paw but not face regions yielded retrograde labeling in the thalamic ventrolateral nucleus. Thus, the distal limb representations in SI and SII each receive inputs from a third major relay nucleus (i.e., medial geniculate to SII, ventrolateral nucleus to SI) whereas the face representations do not. These results indicate a close functional interrelationship between homotypical areas in SI and SII, though the two areas differ in several important respects. It is proposed that SII in mice may complement the function of SI by helping to define the overall sensory context in which detailed tactile discriminations are made. 相似文献
Experimental and clinical studies are progressing simultaneously to investigate the mechanisms and efficacy of progenitor cell treatment after an acute myocardial infarction and in chronic congestive heart failure. Multipotent progenitor cells appear to be capable of improving cardiac perfusion and/or function; however, the mechanisms still are unclear, and the issue of whether or not trans-differentiation occurs remains unsettled. Both experimentally and clinically, cells originating from different tissues have been shown capable of restoring cardiac function, but more recently multiple groups have identified resident cardiac progenitor cells that seem to participate in regenerating the heart after injury. Clinically, cells originating from blood or bone marrow have been proven to be safe whereas injection of skeletal myoblasts has been associated with the occurrence of ventricular arrhythmias. Myoblasts can transform into rapidly beating myotubes; however, thus far convincing evidence for electro-mechanical coupling between myoblasts and cardiomyocytes is lacking. Moving forward, mechanistic studies will benefit from the use of genetic markers and Cre/lox reporter systems that are less prone to misinterpretation than fluorescent antibodies, and a more convincing answer regarding therapeutic efficacy will come from adequately powered randomized placebo controlled trials. 相似文献
Background. Patients not amenable to complete myocardial revascularization by conventional methods present a difficult clinical problem. Here we present the early results and technical considerations of the administration of basic fibroblast growth factor for the induction of collateral growth using heparin-alginate slow-release devices in patients undergoing coronary artery bypass grafting.
Methods. Eight patients were enrolled. Patients were candidates if they had at least one graftable obstructed coronary artery and at least one major arterial distribution not amenable to revascularization, a serum creatinine level less than 3 mg/dL, ejection fraction greater than 0.20, and estimated operative mortality of less than 25%. During conventional coronary artery bypass grafting, 10 heparin-alginate devices, each containing either 1 μg or 10 μg of basic fibroblast growth factor, were implanted in the epicardial fat in multiple regions of the unrevascularizable territory and also in the distal distribution of a grafted or patent artery.
Results. There was no mortality and no evidence of renal, hematologic, or hepatic toxicity during follow-up. Three months after the operation, all patients remain free of angina. Seven patients were examined with stress perfusion scans. Three patients had clear enhancement of perfusion to the unrevascularized myocardium, 1 patient had a new fixed defect, and 3 had minimal overall change but had evidence of new small, fixed perfusion defects. Seven patients had improved or similar myocardial contractile function (ejection fraction at 3-month follow-up = 0.53 ± 0.22 versus 0.47 ± 0.14 preoperatively). One patient suffered a perioperative myocardial infarction in the area of basic fibroblast growth factor administration.
Conclusions. This preliminary study demonstrates the safety and technical feasibility of therapeutic angiogenesis with basic fibroblast growth factor delivered by heparin-alginate slow-release devices. Further studies examining the safety, clinical efficacy, and long-term results are ongoing. 相似文献
Recombinant human granulocyte colony-stimulating factor (G-CSF) treatment has been shown to increase average neutrophil counts substantially in patients with childhood-onset cyclic neutropenia (or "cyclic hematopoiesis"), but not to eliminate the cyclic oscillations of neutrophil counts or those of other blood elements (monocytes, platelets, eosinophils, and reticulocytes) that are characteristic of this hematopoietic disorder. Indeed, oscillations of neutrophil counts are amplified during G-CSF treatment. We have compared the effects of recombinant granulocyte-macrophage-CSF (GM-CSF) with those of G-CSF in three patients with this disease (2 men and 1 woman, 17, 30, and 32 years of age). These patients were treated with GM-CSF (2.1 micrograms/kg/day, subcutaneously) for 6 weeks, preceded and followed by 6 to 13 weeks of detailed observation to document changes in the cyclic oscillations of blood neutrophils and other blood elements; two of the patients were subsequently treated with G-CSF (5.0 micrograms/kg/d, subcutaneously) and observed for comparable periods of time. Unlike G-CSF treatment, which increased average neutrophil counts more than 20-fold, GM-CSF increased neutrophil counts only modestly, from 1.6- to 3.9-fold, although eosinophilia of varying prominence was induced in each patient. However, at the same time, GM-CSF treatment dampened or eliminated the multilineage oscillations of circulating blood elements (neutrophils, monocytes, platelets, and/or reticulocytes) in each of the patients. In contrast, G-CSF treatment of the same patients markedly amplified the oscillations of neutrophil counts and caused the cycling of other blood elements (monocytes in particular) to become more distinct. These findings support the conclusion that the distinctive cycling of blood cell production in childhood-onset cyclic neutropenia results from abnormalities in the coordinate regulation of both GM-CSF-responsive, multipotential progenitor cells and G-CSF-responsive, lineage-restricted, neutrophil progenitors. 相似文献